After subcutaneous injection, LO2 cells with Nogo-B overexpression displayed faster and more sustainable tumor growth in the xenograft model compared with empty vector control group (Fig. 1h and Supplementary Fig. 1K). The gene discussed is RTN4; the disease is neoplasm.